Publications by authors named "Alan T Chang"

Claim this Profile
D
Determination of Optimal Eosinophil Thresholds for Diagnosis of Eosinophilic Gastritis and Duodenitis: A Pooled Analysis of 4 Prospective Studies.
Evan S Dellon, Enoch Bortey, Alan T Chang, Craig A Paterson, Kevin Turner

Clin Transl Gastroenterol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial.
Frank Siebenhaar, Sabine Altrichter, Hanna Bonnekoh, Tomasz Hawro, Marlena Hawro, Alan T Chang

Br J Dermatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Siglecs in allergy and asthma.
Bruce S Bochner, Jeremy A O'Sullivan, Alan T Chang, Bradford A Youngblood

Mol Aspects Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Discovery Rate of Duodenal and Gastric Eosinophilia in Patients With Unexplained Moderate-Severe Abdominal Symptoms: A Prospective US Multisite Study.
Nicholas J Talley, Kathryn A Peterson, Robert M Genta, Alan T Chang, Evan S Dellon

Gastroenterology· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lirentelimab for severe and chronic forms of allergic conjunctivitis.
Stephen D Anesi, Joseph Tauber, Quan Dong Nguyen, Peter Chang, Gregg J Berdy, Alan T Chang

J Allergy Clin Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria.
Sabine Altrichter, Petra Staubach, Malika Pasha, Bhupinder Singh, Alan T Chang

J Allergy Clin Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab.
Evan S Dellon, Nirmala Gonsalves, Marc E Rothenberg, Ikuo Hirano, Mirna Chehade, Alan T Chang

Clin Gastroenterol Hepatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery, Function, and Therapeutic Targeting of Siglec-8.
Bradford A Youngblood, John Leung, Rustom Falahati, Jason Williams, Julia Schanin, Alan T Chang

Cells· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.
Evan S Dellon, Kathryn A Peterson, Joseph A Murray, Gary W Falk, Nirmala Gonsalves, Alan T Chang

N Engl J Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophil and mast cell Siglecs: From biology to drug target.
Jeremy A O'Sullivan, Alan T Chang, Bradford A Youngblood, Bruce S Bochner

J Leukoc Biol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis